Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filters

PublicationDisease areaApplication areaSample typeProducts

Sexual Medicine, 2024
Inflammatory proteins mediate male erectile dysfunction via plasma metabolites

Kang Z., Zhang Z., Feng Z. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Epilepsy & Behavior, 2024
Assessing the impact of circulating inflammatory cytokines and proteins as drivers and therapeutic targets in epilepsy: A Mendelian randomization study

Wang W., Ma L., Liu M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

New England Journal of Medicine, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

Oikonomou V., Smith G., Constantine G. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

European Heart Journal: Acute Cardiovascular Care, 2024
Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit

Patel S., Lopes M., Morrow D. et al.

Olink Target 96CVDPatient StratificationBlood

Analytical Chemistry, 2024
Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates

Beutgen V., Bhagwat A., Steitz A. et al.

Olink Target 96Infectious DiseasesTechnical EvaluationCell Culture Supernatant

GeroScience, 2024
Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and incident dementia: The UK Biobank study

Beydoun H., Beydoun M., Noren Hooten N. et al.

Olink Explore 3072/384NeurologyOther Diseases & SyndromesPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19

Sun J., Edsfeldt A., Svensson J. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of Clinical Medicine, 2024
A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research

Menéndez-Valladares P., Acevedo Aguilera R., Núñez-Jurado D. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature Aging, 2024
A plasma protein-based risk score to predict hip fractures

Austin T., Nethander M., Fink H. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

Movement Disorders, 2024
Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts

Khosousi S., Sturchio A., Appleton E. et al.

Olink Target 96NeurologyPatient StratificationCSF

Thrombosis and Haemostasis, 2024
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study

Zhang B., He R., Yao Z. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

PROTEOMICS, 2024
Capillary blood self‐collection for high‐throughput proteomics

El‐Sabawi B., Huang S., Tanriverdi K. et al.

Olink Explore 3072/384Wider Proteomics StudiesTechnical EvaluationCapillary BloodBlood

Science Translational Medicine, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes

Chen Z., Satake E., Pezzolesi M. et al.

Olink Target 96NephrologyPathophysiologyPatient StratificationPlasma

International Journal of Obesity, 2024
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study

Fryk E., Rodrigues Silva V., Strindberg L. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

International Urology and Nephrology, 2024
Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study

Yuan D., Yang J., Wu W. et al.

Olink Target 96NephrologyPathophysiologyPlasma

Biomedicines, 2024
Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy

Song Y., Pan S., Tian J. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma

BMC Medical Genomics, 2024
Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis

Tan C., Li Y., Wang K. et al.

Olink Target 96OncologyCVDPathophysiologyPlasma

iScience, 2024
Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior

Jansen S., Cutilli A., de Koning C. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Scientific Reports, 2024
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

Grauen Larsen H., Sun J., Sjögren M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Therapeutic Advances in Medical Oncology, 2024
Multiplex analysis for the identification of plasma protein biomarkers for predicting lung cancer immunotherapy response

Hong M., Lee S., Cho B. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

1889 publications